AstraZeneca Calls For Newly Approved Drugs To Carry Symbol In Labeling
This article was originally published in The Pink Sheet Daily
Executive Summary
A white paper released by the company argues against an "arbitrary" DTC moratorium on new drugs.
You may also be interested in...
AstraZeneca Rx Promotions Subject Of U.S. Attorney Investigation
The Los Angeles U.S. Attorney’s Office is examining the company’s local field promotions.
AstraZeneca Rx Promotions Subject Of U.S. Attorney Investigation
The Los Angeles U.S. Attorney’s Office is examining the company’s local field promotions.
Pfizer Guidelines Call For Physician Education For Six Months Prior To DTC
Stay on DTC is more specific than PhRMA’s DTC guiding principles, which require an “appropriate amount of time” be spent on physician education prior to campaign launch.